Pharmaceutical expertise included
Human and veterinary vaccines have been developed and made at the location of Dessau in Saxony-Anhalt since 1921. Today, Dessau is home to the BioPharmaPark, which occupies a 120-hectare site. The state-of-the-art location – situated 90 kilometres south of Berlin and 60 kilometres north of Leipzig – has developed into a global centre for pharmaceutical and biotechnology.
The businesses that are based here have considerable expertise in the production and packaging of pharmaceuticals, in innovative vaccine technology, in quality control and compliance, as well as in research and development. In addition to the synergies that they make use of here, the companies also benefit from a highly efficient production infrastructure – in particular, that includes the company IDT Biologika, which emerged from the long standing business for the manufacturing of vaccines.
The company Technik-Energie-Wasser Servicegesellschaft mbH (TEW) was created in order to support the development of the BioPharmaPark Dessau. TEW creates no-worries packages for both established companies and start-ups.
Andreas Kastenbauer, Managing Director of Technik-Energie-Wasser Servicegesellschaft mbh
“In the event that they decide to set up at the BioPharmaPark, future location partners and interested parties can rely on the expertise of TEW – from the application and approval process to the implementation of the construction project,” says Andreas Kastenbauer, Managing Director of TEW. All in all, the service network of the Biopharmapark minimises the costs and business risks and facilitates access to markets and customers.”
Total area in hectare
Total investments in Mio. € (since 2011)
Available Area in hektare
Distance to airport Halle/Leipzig in kilometers
- Vaccines and pharmaceuticals for the preservation of the health of humans and animals (IDT Biologika)
- Livestock-specific vaccines (animal health), pharmaceutical active ingredients, fine chemicals and special polymers (Dr. Felgenträger & Co. - Öko-chem. und Pharma GmbH)
- Production and development of aseptically produced cytostatic drugs (Oncotec Pharma Produktion GmbH)
- Botulinum toxin and dermal fillers (Merz Pharma GmbH & Co. KGaA)
RESIDENT RESEARCH INSTITUTES
- BioPharma Translations Institute Dessau Research GmbH (BTI)
- German Center for Infection Research, with 35 research institutions at 7 locations in Germany
- Jefferson Vaccine Center at the Thomas Jefferson University Philadelphia, U.S.A.
- Infectious Disease Research Institute (IDRI), Seattle, U.S.A.
- Erasmus Medical Center, Amsterdam, Netherlands
- Cr2O, Clinical Research Institution, Amsterdam, Netherlands